WDNA ETF
Wisdomtree BioRevolution Fund
WDNA ETF Overview
WDNA ETF (Wisdomtree BioRevolution Fund) is managed by WisdomTree Investments with $2.8M in net assets. WDNA expense ratio is 0.45%, holding 84 positions across sectors including Health Care, Materials, Consumer Staples. Inception date: 2021-06-03.
WDNA performance shows a YTD return of 14.21%. The 1-year return is 46.78% and the 5-year return is -4.38%. WDNA dividend yield stands at 3.97%, paid annually.
WDNA top holdings include Moderna therapeutics (4.4%), Johnson & Johnson - Common (3.1%), Pfizer Inc (2.8%), Eli Lilly & Co. (2.7%), United Therapeutics Corp (2.7%). Go to all WDNA holdings, WDNA sectors, or WDNA dividends.
WDNA can be compared against other funds. Use WDNA overlap to find shared positions, or WDNA vs another fund for a side-by-side view. WDNA alternatives are available via the screener, along with tax-loss harvesting opportunities.